Ads
related to: co primary endpoint evaluation tool- API Tests & Checks
Ensure Uptime, Identify Regional
Issues, & Track App Performance
- Automated Browser Testing
Save Time With Codeless
Self-Healing Browser Tests
- Frontend Observability
Deliver Consistent And Exceptional
Digital Experiences With Datadog.
- Request A Datadog Demo
See Datadog Observability In Action
Watch It Today
- Datadog Free Trial
Sign Up Today For A Free Trial
And See Value Immediately.
- Real-Time UX Monitoring
Ensure Reliable User Experiences
Across Web And Mobile Applications.
- API Tests & Checks
Search results
Results From The WOW.Com Content Network
The primary endpoint of a clinical trial is the endpoint for which the trial is powered. Secondary endpoints are additional endpoints, preferably also pre-specified, for which the trial may not be powered.
As an interview-based assessment of cognition, the SCoRS meets the criteria established by the FDA National Institute of Mental Health (NIMH) Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) panel [5] for co-primary outcome measures for cognitive enhancement trials in schizophrenia.
An outcome measure, endpoint, effect measure or measure of effect is a measure within medical practice or research, (primarily clinical trials) which is used to assess the effect, both positive and negative, of an intervention or treatment. [1] [2] Measures can often be quantified using effect sizes. [3]
Only patients with measurable disease at baseline should be included in protocols where objective tumor response is the primary endpoint. Measurable disease – the presence of at least one measurable lesion. If the measurable disease is restricted to a solitary lesion, its neoplastic nature should be confirmed by cytology/histology.
The clinical global impression – severity scale (CGI-S) is a 7-point scale that requires the clinician to rate the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis. Clinicians ask: "Considering your total clinical experience with this particular ...
Major adverse cardiovascular events (MACE, or major adverse cardiac events) is a composite endpoint frequently used in cardiovascular research. [ 1 ] [ 2 ] Despite widespread use of the term in clinical trials, the definitions of MACE can differ, which makes comparison of similar studies difficult.
A surrogate endpoint of a clinical trial is a laboratory measurement or a physical sign used as a substitute for a clinically meaningful endpoint that measures directly how a patient feels, functions or survives. Changes induced by a therapy on a surrogate endpoint are expected to reflect changes in a clinically meaningful endpoint. [8]
Turquoise II was an open-label, randomized trial which had a primary endpoint of cure (SVR 12) rate in patients with compensated cirrhosis and either HCV GT1a or GT1b and both treatment arms were given Viekira Pak and (RBV). The two treatment arms differed by length of treatment: subjects were randomly assigned to receive treatment for either ...
Ad
related to: co primary endpoint evaluation tool